Research News

- Read more about Bioengineers' sweat sensor monitors glucose
Researchers at The University of Texas at Dallas are sweating the small stuff in their efforts to develop a wearable device that can monitor an individual's glucose level via perspiration on the skin.
- Read more about N-acetyl cysteine improves efficacy of adoptive T cell immunotherapy for melanoma
A collaborative team of investigators at the Medical University of South Carolina (MUSC) and Loyola University have demonstrated for the first time that culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma.
- Read more about Triple-drug chemotherapy with topotecan helps preserve vision in retinoblastoma patients
St. Jude Children’s Research Hospital researchers report a topotecan-based chemotherapy regimen should be considered front-line therapy for patients with advanced bilateral retinoblastoma; an eye cancer in young children.
- Read more about Are natural alternatives to estrogen replacement therapy safe
Although individuals often consume natural products because of their potential health benefits, a new review indicates that it is not clear whether the benefits of plant-derived compounds that mimic estrogen outweigh the possible health risks. The findings are published in the British Journal of Pharmacology.
- Read more about Nivolumab reduces symptoms in relapsed metastatic head and neck cancer
Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial presented at the ESMO 2016 Congress in Copenhagen1 and published in the New England Journal of Medicine.
- Read more about Janssen present New Phase 3 Data In Treatment of Moderate to Severe Plaque Psoriasis
Janssen Research & Development, LLC (Janssen) announced findings from the first of three pivotal Phase 3 studies evaluating guselkumab, a subcutaneously administered anti-interleukin (IL)-23 monoclonal antibody in late-stage development for the treatment of adults with moderate to severe plaque psoriasis.
- Read more about Sanofi Pasteur received approval for Dengvaxia® dengue vaccine
Sanofi Pasteur, the vaccines global business unit of Sanofi, announced Dengvaxia® dengue vaccine has now received its 11th marketing approval, four of which granted from Regulatory Authorities recognized by the World Health Organization (WHO). To date the vaccine is approved in Mexico, The Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore.
- Read more about Life saving drug, D-Penicillamine is not availble in indian market
Life saving drug (D-Penicillamine) is not available across India. And CDSCO working faster on availability of drug in the market.
- Read more about Cancer Research UK, MSD and Verastem Collaborate to Trial New Combination of Immunotherapy Drugs
MSD, Verastem, Inc. and Cancer Research UK will trial a new combination of immunotherapy drugs in mesothelioma, non small cell lung and pancreatic cancers. The trial will run through the ECMC network at centres in Edinburgh-Dundee, Southampton, Glasgow, Leicester and Belfast.

[adsense:336x280:8701650588]
- Read more about Nanobiomed Inc® Discovered a New Nuclear Staining Molecule and Eco-Friendly Natural Source for Cancer Diagnostics: Prextrolin®
Nanobiomed Inc®., a nanomedicine and biotechnology company announced its leading-edge development of a new molecule for use in tissue and cancer diagnostics.